Skip to content
PeptideAgent

Compounding pharmacies in Washington

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

The Washington Pharmacy Quality Assurance Commission (Washington State Department of Health) regulates compounding pharmacies in Washington. Compounded GLP-1 limited. How to check a pharmacy's license, plus verified listings.

Washington at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async unclear
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified compounding pharmacies serving Washington

No verified compounding pharmacies serving Washington are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Who regulates compounding pharmacies in Washington

In Washington the pharmacy regulator is a commission rather than a board: the Pharmacy Quality Assurance Commission (PQAC) regulates the practice of pharmacy and the distribution of drugs within and into the state under chapter 18.64 RCW and its consolidated rule chapter, WAC 246-945. WAC 246-945-100 requires every licensee that compounds sterile or non-sterile preparations to comply with the applicable USP chapters (795, 797, 800, and 825). RCW 18.64.360 requires nonresident pharmacies to be licensed and to submit a current inspection report from an approved state or third-party program; the Commission accepts reports from non-approved states only for pharmacies that do not compound. Washington has no separate state list of compoundable bulk substances, so a peptide's eligibility follows the federal 503A test (approved drug component, USP or NF monograph, or FDA 503A bulks list). [1] [2] [3] [4] [6]

Compounded GLP-1 access in Washington

Because a nonresident pharmacy that compounds must supply an inspection report from an approved program to keep its Washington license, patients can confirm eligibility through the Department of Health provider credential search. [1] [3] [9]

Research use only sellers in Washington

Chapter 69.41 RCW makes it unlawful to sell, deliver, or possess a legend (prescription) drug except on a valid prescription or as otherwise authorized (RCW 69.41.030), and pharmacy distribution into Washington requires Commission licensure under chapter 18.64 RCW. [2] [5] [10]

Washington notes on specific peptides

  • BPC-157: Not FDA approved and not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk; a state board cannot authorize what federal law does not. The Pharmacy Quality Assurance Commission has not published a peptide-specific rule. [1] [7] [8]

How to check a compounding pharmacy in Washington

  1. Search the Washington Pharmacy Quality Assurance Commission (Washington State Department of Health) license lookup for the pharmacy by name. A pharmacy based elsewhere needs whatever license or registration Washington requires before it ships to you. [1] [2] [3] [4] [6]
  2. Ask whether it operates as a 503A pharmacy or a 503B outsourcing facility, and confirm a 503B claim against FDA's outsourcing facility information (see the verification checklist).
  3. Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Washington. [2] [5] [10]

Common questions in Washington

What does an out-of-state compounding pharmacy need to ship to Washington?

A Washington nonresident pharmacy license under RCW 18.64.360, supported by a current inspection report from an approved state or third-party program. Pharmacies that compound cannot rely on reports from non-approved states, and all compounding must follow the USP chapters in WAC 246-945-100. [3] [4]

All peptide legal questions for Washington

Sources

  1. [1]Washington Pharmacy Quality Assurance Commission (Department of Health)
  2. [2]Chapter 18.64 RCW, Pharmacists
  3. [3]RCW 18.64.360, Nonresident pharmacies
  4. [4]Chapter 246-945 WAC, Pharmacy Quality Assurance Commission (including WAC 246-945-100, compounding minimum standards)
  5. [5]RCW 69.41.030, Sale, delivery, or possession of legend drug without prescription or order prohibited
  6. [6]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  7. [7]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA
  8. [8]FDA: Pharmacy Compounding Advisory CommitteeFDA
  9. [9]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  10. [10]21 U.S.C. 331, Prohibited acts